A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a ...

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...

It is called HUNK (acronym of Hormonally Upregulated Neu-associated Kinase) and it is a new biomarker for gastric cancer: it ...

Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...